Mind Medicine Mindmed Inc (MNMD)
$9.40
0.03 (0.27%)
MNMD Stock Quote Delayed 30 Minutes
3 Psychedelic Stocks to Ride to the Moon and Beyond
Psychedelic stocks are a hot, trending area of investment as the FDA continues to weigh regulatory considerations that will open the market.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
764,042
Day's Range
$9.36 - $9.83
52-Week Range
$2.41 - $12.22
Dividend & Yield
N/A (N/A)
MNMD Stock Predictions, Articles, and Mind Medicine Mindmed Inc News
MNMD Stock Earnings: Mind Medicine Misses EPS for Q1 2024
MNMD stock results show that Mind Medicine missed analyst estimates for earnings per share the first quarter of 2024.
Why Is MindMed (MNMD) Stock Up 32% Today?
MindMed stock is heading higher on Thursday as MNMD investors celebrate it getting breakthrough designation from the FDA!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are worth checking out on Thursday to get an idea of the hottest stocks worth watching this morning!
Why Is MindMed (MNMD) Stock Up 8% Today?
MindMed and other psychedelic stocks are rising today on news of an FDA priority review. Here's what this means for MNMD stock and its peers.
Why Is Mind Medicine (MNMD) Stock Up 26% Today?
Mind Medicine (MNMD) stock is on the rise Friday after releasing positive results from a Phase 2 clinical trial of lysergide (LSD).
Mind Medicine’s Bad Trip Won’t End Anytime Soon
Trouble abounds as Mind Medicine proposes a huge sale of MNMD stock shares and an activist investor threatens the company's board.
What Is Going on With Bright Minds (DRUG) Stock Today?
Here's why investors in Bright Minds and DRUG stock are cheering some recent rhetoric from Sen. Cory Booker today.
Cory Booker Sends MindMed (MNMD) Stock Up 10%
Mind Medicine (MNMD) stock is heating up on Tuesday thanks to tweets from Senator Cory Booker calling for changes to regulations on psychedelics.
Why Is MindMed (MNMD) Stock Plunging 51% Today?
MNMD stock is tumbling more than 50% after the drug maker announced that it would sell shares of its stock and warrants for its shares.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning.
MindMed (MNMD) Stock Regains Nasdaq Compliance
MindMed (MNMD) stock is in the news Wednesday after the psychedelic medicine company regained Nasdaq minimum price compliance.
MindMed (MNMD) Stock Is Up on Psychedelics News
MindMed (MNMD) stock is on the move Wednesday following positive data from a Phase II clinical trial of MM-120 for anxiety.
